Does FENOFIBRATE Cause Mobility decreased? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Mobility decreased have been filed in association with FENOFIBRATE (Fenofibrate). This represents 0.2% of all adverse event reports for FENOFIBRATE.
14
Reports of Mobility decreased with FENOFIBRATE
0.2%
of all FENOFIBRATE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Mobility decreased From FENOFIBRATE?
Of the 14 reports, 11 (78.6%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FENOFIBRATE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does FENOFIBRATE Cause?
Myalgia (411)
Dyspnoea (373)
Fatigue (365)
Asthenia (356)
Dizziness (356)
Fall (354)
Drug ineffective (326)
Pruritus (325)
Nausea (311)
Diarrhoea (310)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which FENOFIBRATE Alternatives Have Lower Mobility decreased Risk?
FENOFIBRATE vs FENOFIBRIC ACID
FENOFIBRATE vs FENOTEROL
FENOFIBRATE vs FENOTEROL HYDROBROMIDE
FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM
FENOFIBRATE vs FENTANYL